U.S. Patent No. 7,200,760 covers persistent encryption of software data to control the operation of an executable. The approved claims in the forthcoming patent cover additional unique product activation technology for publishers of digital content to market and license their software," said Karl Hirsch, CEO of Protexis. “Users also benefit from this technology which affords simplified and efficient real-time digital packaging of multiple protected items and decryption of these items.”

“Protexis is committed to building an intellectual property portfolio around our proven expertise in online content distribution, electronic software distribution, digital rights management, and product activation,” added Hirsch. “The patent portfolio we have developed spans more than a decade. Our company launched the world's first commercial product activation based anti-piracy technology following those early patents, and now we are building further on that IP foundation to change the face of digital content distribution with our latest services breakthrough, REDSM - Retail Electronic Distribution.

"Receiving these new patents further validates the strength and scope of Protexis’ patent portfolio and its vision to provide the infrastructure for efficient global distribution of digital content for publishers and their retail partners,” added Hirsch.

About Protexis

Protexis is the leader in digital content distribution for retailers. The company’s patented REDSM system enables the first and only open, neutral and efficient network for online digital content distribution. Protexis brings retailers and publishers together, giving them trusted control, to reach an expanded global community of millions of customers, efficiently and securely. Protexis currently serves large online retailers and over 2,000 software publishers. The company holds a total of six issued and 11 pending United States and international patents, and continues to focus on increasing its portfolio of intellectual property. Protexis is privately held, with headquarters in Vancouver, British Columbia, and offices in Seattle. For more information, please visit www.protexis.com.